Managers / Q1 2024 · view latest →
BRANDYWINE MANAGERS, LLC
CIK 0001135121 · 7234 LANCASTER PIKE, HOCKESSIN, DE, 19707 · 302-234-5705
Summary
Brandywine Managers, LLC reported $101M in U.S.-listed holdings across 40 positions for Q1 2024.
The portfolio is heavily concentrated: ACWI alone accounts for 38.0% of reported value.
Compared with Q4 2023, the fund opened 0 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 61.5% · $62M
- ETP · 38.0% · $39M
- ADR · 0.5% · $514,620
Quarter-over-Quarter Changes full breakdown →
vs Q4 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SSENTINELONE INC | SOLD OUT | −7.9K | 0 | −$216,776 | $0 |
| DNLIDENALI THERAPEUTICS INC | SOLD OUT | −9.6K | 0 | −$206,037 | $0 |
| ACWIISHARES TR | ADDED | +49.7K | 349.8K | +$8M | $39M |
| PANWPALO ALTO NETWORKS INC | ADDED | +370 | 4.1K | +$65,300 | $1M |
| CRWDCROWDSTRIKE HLDGS INC | HELD | +954 | 30.8K | +$2M | $10M |
| PATHUIPATH INC | HELD | +0 | 1.01M | −$2M | $23M |
| NVDANVIDIA CORPORATION | HELD | +0 | 3.6K | +$1M | $3M |
| NTRANATERA INC | HELD | +0 | 17.4K | +$502,736 | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | ACWIISHARES TRhistory → | MSCI ACWI ETF | 38.02% | $39M | 349.8K |
| 2 | PATHUIPATH INChistory → | CL A | 22.52% | $23M | 1.01M |
| 3 | CRWDCROWDSTRIKE HLDGS INChistory → | CL A | 9.75% | $10M | 30.8K |
| 4 | NVDANVIDIA CORPORATIONhistory → | COM | 3.18% | $3M | 3.6K |
| 5 | UBERUBER TECHNOLOGIES INChistory → | COM | 2.19% | $2M | 28.8K |
| 6 | CRMSALESFORCE INChistory → | COM | 2.06% | $2M | 6.9K |
| 7 | NTRANATERA INChistory → | COM | 1.57% | $2M | 17.4K |
| 8 | ZSZSCALER INChistory → | COM | 1.41% | $1M | 7.4K |
| 9 | ISRGINTUITIVE SURGICAL INChistory → | COM NEW | 1.31% | $1M | 3.3K |
| 10 | AMDADVANCED MICRO DEVICES INChistory → | COM | 1.30% | $1M | 7.3K |
| 11 | PANWPALO ALTO NETWORKS INChistory → | COM | 1.14% | $1M | 4.1K |
| 12 | OKTAOKTA INChistory → | CL A | 1.06% | $1M | 10.2K |
| 13 | CPBCAMPBELL SOUP COhistory → | COM | 1.05% | $1M | 24.0K |
| 14 | MRNAMODERNA INChistory → | COM | 1.00% | $1M | 9.5K |
| 15 | VEEVVEEVA SYS INC | CL A COM | 0.90% | $907,993 | 3.9K |
| 16 | IOTSAMSARA INC | COM CL A | 0.88% | $891,013 | 23.6K |
| 17 | DDOGDATADOG INC | CL A COM | 0.88% | $889,920 | 7.2K |
| 18 | MAMASTERCARD INCORPORATED | CL A | 0.85% | $859,602 | 1.8K |
| 19 | TWSTTWIST BIOSCIENCE CORP | COM | 0.71% | $719,481 | 21.0K |
| 20 | MORFUSDMORPHIC HLDG INC | COM | 0.70% | $714,067 | 20.3K |
| 21 | PDPAGERDUTY INC | COM | 0.68% | $692,126 | 30.5K |
| 22 | NOWSERVICENOW INC | COM | 0.67% | $680,823 | 893 |
| 23 | ALNYALNYLAM PHARMACEUTICALS INC | COM | 0.64% | $649,809 | 4.3K |
| 24 | TWLOTWILIO INC | CL A | 0.59% | $598,169 | 9.8K |
| 25 | SDGRSCHRODINGER INC | COM | 0.56% | $563,922 | 20.9K |
| 26 | GPCRSTRUCTURE THERAPEUTICS INC | SPONSORED ADS | 0.51% | $514,620 | 12.0K |
| 27 | MBLYMOBILEYE GLOBAL INC | COMMON CLASS A | 0.41% | $420,104 | 13.1K |
| 28 | SNOWSNOWFLAKE INC | CL A | 0.41% | $411,918 | 2.5K |
| 29 | TXG10X GENOMICS INC | CL A COM | 0.37% | $378,040 | 10.1K |
| 30 | SMARGBPSMARTSHEET INC | COM CL A | 0.29% | $296,450 | 7.7K |
| 31 | GHGUARDANT HEALTH INC | COM | 0.29% | $295,071 | 14.3K |
| 32 | RBLXROBLOX CORP | CL A | 0.27% | $276,461 | 7.2K |
| 33 | BEAMBEAM THERAPEUTICS INC | COM | 0.26% | $266,534 | 8.1K |
| 34 | RLAYRELAY THERAPEUTICS INC | COM | 0.26% | $263,998 | 31.8K |
| 35 | ABCLABCELLERA BIOLOGICS INC | COM | 0.25% | $258,101 | 57.0K |
| 36 | DOCUDOCUSIGN INC | COM | 0.25% | $250,765 | 4.2K |
| 37 | FULCFULCRUM THERAPEUTICS INC | COM | 0.24% | $246,639 | 26.1K |
| 38 | PRMEPRIME MEDICINE INC | COM | 0.23% | $230,839 | 33.0K |
| 39 | UUNITY SOFTWARE INC | COM | 0.22% | $222,331 | 8.3K |
| 40 | SEERSEER INC | COM CL A | 0.08% | $84,649 | 44.6K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $170M | 40 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $202M | 38 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $104M | 37 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $101M | 36 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $83M | 35 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $95M | 37 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $93M | 35 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $95M | 36 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $101M | 40 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $91M | 42 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $59M | 38 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $151M | 48 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $141M | 48 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $29M | 37 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $30M | 39 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $41M | 42 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $58M | 42 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $88M | 43 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $96M | 44 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $88M | 45 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $75M | 46 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $73M | 42 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $53M | 40 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $24M | 40 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $284M | 38 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $334M | 49 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $299M | 48 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $267M | 48 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $250M | 48 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $212M | 46 | Feb 12, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 6 additional managers.
- GARDNER RUSSO & QUINN LLC028-02635
- PARAMETRIC PORTFOLIO ASSOCIATES LLC028-04558
- Aperio Group, LLC028-11964
- BrandyTrust Global Partners, LP028-18174
- ABANCO INVESTORS LTD., LLC028-06287
- RDZ Family, LLC028-23262
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.